Abstract:Background: Nasopharyngeal carcinoma (NPC) is a relatively common type of cancer in Southern China, with local recurrence or distant metastases even after radical treatment; consequently, it is critical to identify the patients at higher risk for these events beforehand. This study aimed to assess the prognostic value of regional lymph node density (RLND) associated nomograms in NPC and to evaluate the utility of nomograms in risk stratification. Methods: A total of 610 NPC patients without distant metastases (425 in the training and 185 in the validation cohort) were enrolled. The MRI-identified nodal features and clinical characteristics were documented, and the RLND was calculated. Cox analyses were conducted to identify prognostic-associated factors. Nomograms were generated based on the multivariate analysis results. The predictive accuracy and discriminative ability of the nomogram models were determined using the concordance index (C-index), receiver operating characteristic (ROC) curve, and calibration curve; the results were compared with those of the tumor-node-metastasis (TNM) classification. Decision curve analysis (DCA) and C-index were used to assess the prognostic effect and added discriminative ability of RLND. We also estimated the optimal RLND-based nomogram score cut-off values for survival prediction. Results: RLND was an independent predictor of overall survival (OS) and disease-free survival (DFS), with hazard ratios of 1.36 and 1.30, respectively. RLND was utilized in the construction of nomograms, alongside other independent prognostic factors. The RLND-based nomogram models presented a more effective discriminative ability than the TNM classification for predicting OS (C-index, 0.711 vs. 0.680) and DFS (C-index, 0.681 vs. 0.669), with favorable calibration and consistency. The comparison of C-index values between the nomogram models with and without RLND provided substantiation of the crucial role RLND plays in these models. DCA confirmed the satisfactory clinical practicability of RLND. Moreover, the nomograms were used to categorize the patients into three groups (high-, middle-, and low-risk), and the Kaplan-Meier curves showed significant differences in prognosis between them (p < 0.05). These results were verified in the validation cohort. Conclusion: RLND stands as a robust prognostic factor in NPC. The RLND-based nomograms excel in predicting survival, surpassing the TNM classification.

AI-Based Risk Score from Tumour-Infiltrating Lymphocyte Predicts Locoregional-Free Survival in Nasopharyngeal Carcinoma

Prognostic Value of Immune Score in Nasopharyngeal Carcinoma Using Digital Pathology

Integrative Scoring System for Survival Prediction in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Multicenter Study

Pretreatment MRI Radiomics Analysis Allows for Reliable Prediction of Local Recurrence in Non-Metastatic T4 Nasopharyngeal Carcinoma.

Development and Validation of the Immune Signature to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma

Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases

Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma

The prognostic value of deep learning-based percentage of tumour-infiltrating lymphocytes in nasopharyngeal carcinoma.

Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network

A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients

Molecular Prognostic Prediction For Locally Advanced Nasopharyngeal Carcinoma By Support Vector Machine Integrated Approach

Development Of A Clinicomolecular Risk Stratification System For Nonmetastatic Nasopharyngeal Carcinoma Using Epstein-Barr Virus Dna And Tnm Stage: A "Big Data" Analysis Of 9,160 Endemic Cases.

A Clinical-Radiomics Nomogram Based on Magnetic Resonance Imaging for Predicting Progression-Free Survival After Induction Chemotherapy in Nasopharyngeal Carcinoma

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Establishment of a Prognostic Scoring Model for Regional Recurrent Nasopharyngeal Carcinoma after Neck Dissection.

Spatial Heterogeneity of Immune Infiltration Predicts the Prognosis of Nasopharyngeal Carcinoma Patients

Distant Metastasis Risk Definition by Tumor Biomarkers Integrated Nomogram Approach for Locally Advanced Nasopharyngeal Carcinoma

Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma

Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Development of a Risk Classification System Combining TN-categories and Circulating EBV DNA for Non-Metastatic NPC in 10,149 Endemic Cases.

Deep convolution neural network model for automatic risk assessment of patients with non-metastatic nasopharyngeal carcinoma